论文部分内容阅读
缓慢性心律失常为临床常见病,患者可出现头晕、黑蒙严重者可引起阿斯综合征甚至心脏停搏。其治疗除安装心内永久起搏器外,药物治疗多予以β-受体兴奋剂(异丙肾上腺素)及迷走神经抑制(阿托品、654-2)。但上述药物的疗效却并不令人满意,且因其具有较大的副作用而限制了临床上的广泛应用。近年来,氨茶碱治疗缓慢性心律失常已成为国内外的研究热点,并以其安全、方便、疗效确切受到国内外学者的肯定。现将近年来氨茶碱治疗缓慢性心律失常的研究进展综述如下。
Bradyarrhythmia is a common clinical disease, patients may be dizzy, severe black can cause Asperger syndrome or cardiac arrest. In addition to the treatment of its installation of the permanent heart pacemaker, the drug treatment for β-receptor agonists (isoproterenol) and vagal inhibition (atropine, 654-2). However, the efficacy of these drugs is not satisfactory, and because of its larger side effects and limits the clinical application. In recent years, aminophylline treatment of bradyarrhythmia has become a research hotspot at home and abroad, and its safety, convenience, efficacy has been affirmed by domestic and foreign scholars. In recent years, aminophylline treatment of bradyarrhythmia are summarized below.